Universe Pharmaceuticals INC Class A(UPC US)
$4.34-0.040.91%Ext:$3.55-0.7918.20%(Market Closed · 23:55:17 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201809/30/2018 | FY201909/30/2019 | FY202009/30/2020 | FY202109/30/2021 | FY202209/30/2022 | FY202309/30/2023 | FY202409/30/2024 | FY202509/30/2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 5.7 | 5.3 | 29.5 | 33.6 | ||||||
| Short Term Investments | 13.1 | 13.2 | - | - | ||||||
| Cash and Short Term Investments | 18.9 | 18.5 | 29.5 | 33.6 | ||||||
| Net Receivables | 15.2 | 10.7 | 17.9 | 13.2 | ||||||
| Inventory | 2.2 | 3.3 | 1.7 | 2.2 | ||||||
| Other Current Assets | 1.7 | 0.6 | 0.9 | 0.0 | ||||||
| Total Current Assets | 41.5 | 36.8 | 51.6 | 53.6 | ||||||
| Property, Plant & Equipment | 13.6 | 15.0 | 15.3 | 14.7 | ||||||
| Long Term Investments | 0.7 | 0.7 | 0.7 | 0.7 | ||||||
| Other Non-Current Assets | 2.2 | - | - | - | ||||||
| Total Non-Current Assets | 18.0 | 16.5 | 16.3 | 15.7 | ||||||
| Total Assets | 59.5 | 53.3 | 68.0 | 69.3 | ||||||
| Account Payables | 3.1 | 4.6 | 4.9 | 1.7 | ||||||
| Short Term Debt | 3.9 | 5.5 | 5.9 | 9.3 | ||||||
| Deferred Revenue | - | - | - | 0.0 | ||||||
| Other Current Liabilities | 3.4 | - | - | - | ||||||
| Total Current Liabilities | 13.1 | 13.8 | 20.3 | 13.2 | ||||||
| Long Term Debt | - | - | 2.1 | - | ||||||
| Other Non-Current Liabilities | - | - | - | - | ||||||
| Total Non-Current Liabilities | 7.0 | - | 2.1 | - | ||||||
| Total Liabilities | 13.1 | 13.8 | 22.5 | 13.2 | ||||||
| Common Stock | 0.1 | 0.1 | 0.5 | 6.3 | ||||||
| Retained Earnings | 16.3 | 10.2 | -10.2 | -13.8 | ||||||
| Total Stockholders Equity | 46.4 | 39.5 | 45.5 | 56.1 | ||||||
| Total Liabilities and Equity | 59.5 | 53.3 | 68.0 | 69.3 | ||||||